Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction

NEXT STORY
Next Generation Sequencing Market Worth US$30,424.3 Million by 2031: Visiongain Research Inc.
PREV STORY
Pomerleau and the MUHC Foundation work toward revolutionizing cancer care across Canada
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2019 Financial Results

author_avatar
NASDAQ Market News

Global Point-of-Care Imaging Devices Market: Focus on Product Type, Technology Type, Clinical Utility, Application, End User, 23 Countries’ Data, COVID-19 Impact, and Competitive Landscape – Analysis and Forecast, 2020-2030

author_avatar
NASDAQ Market News

Family Wellness Center of Norman Hosts Open House to Introduce Newly Offered FDA-Cleared Deep TMS Helmet to Treat Major Depressive Disorder (MDD)

author_avatar
NASDAQ Market News